Cases & Deals

Baxter International invests in Bugworks Research

Clients Baxter International Inc.

Jones Day represented Baxter International Inc. in connection with its purchase of Series Seed Preferred Stock in a private placement by Bugworks Research, Inc., a discovery company that aims to discover novel biopharmaceutical assets for the treatment of antibiotic resistant bacterial infections.